Amgen Inc. (AMGN) Stock Overview
Explore Amgen Inc.’s financial performance, market position, analyst ratings, and future outlook.
Amgen Inc. (AMGN)
Key Financials
Key Financials
Market Cap
236B
P/E Ratio
26.93
EPS (TTM)
$22.37
ROE
0.89%
AMGN Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Amgen Inc. (NASDAQ: AMGN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Amgen Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of AMGN on the NASDAQ shows an RSI of 61.70, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $358.94 for the NASDAQ listing.
Key metrics behind Amgen Inc.'s NASDAQ-traded stock include a P/E ratio of 26.93 and a market capitalization of 236B. Combined with our AI analysis, these give both institutional and retail investors a clear view of AMGN on the NASDAQ.